Your browser doesn't support javascript.
loading
Incident pulmonary hypertension in 13 488 cases investigated with repeat echocardiography: a clinical cohort study.
Stewart, Simon; Chan, Yih-Kai; Playford, David; Harris, Sarah; Strange, Geoffrey A.
Affiliation
  • Stewart S; Institute for Health Research, The University of Notre Dame Australia, Fremantle, WA, Australia.
  • Chan YK; School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.
  • Playford D; Mary MacKillop Institute for Health Research, The Australian Catholic University, Melbourne, VI, Australia.
  • Harris S; Institute for Health Research, The University of Notre Dame Australia, Fremantle, WA, Australia.
  • Strange GA; Institute for Health Research, The University of Notre Dame Australia, Fremantle, WA, Australia.
ERJ Open Res ; 9(5)2023 Sep.
Article in En | MEDLINE | ID: mdl-37701368
ABSTRACT

Background:

We addressed the paucity of data describing the characteristics and natural history of incident pulmonary hypertension.

Methods:

Adults (n=13 448) undergoing routine echocardiography without initial evidence of pulmonary hypertension (estimated right ventricular systolic pressure, eRVSP <30.0 mmHg) or left heart disease were studied. Incident pulmonary hypertension (eRVSP ≥30.0 mmHg) was detected on repeat echocardiogram a median of 4.1 years apart. Mortality was examined according to increasing eRVSP levels (30.0-39.9, 40.0-49.9 and ≥50.0 mmHg) indicative of mild-to-severe pulmonary hypertension.

Results:

A total of 6169 men (45.9%, aged 61.4±16.7 years) and 7279 women (60.8±16.9 years) without evidence of pulmonary hypertension were identified (first echocardiogram). Subsequently, 5412 (40.2%) developed evidence of pulmonary hypertension, comprising 4125 (30.7%), 928 (6.9%) and 359 (2.7%) cases with an eRVSP of 30.0-39.9 mmHg, 40.0-49.9 mmHg and ≥50.0 mmHg, respectively (incidence 94.0 and 90.9 cases per 1000 men and women, respectively, per year). Median (interquartile range) eRVSP increased by +0.0 (-2.27 to +2.67) mmHg and +30.68 (+26.03 to +37.31) mmHg among those with eRVSP <30.0 mmHg versus ≥50.0 mmHg. During a median 8.1 years of follow-up, 2776 (20.6%) died from all causes. Compared to those with eRVSP <30.0 mmHg, the adjusted risk of all-cause mortality was 1.30-fold higher in 30.0-39.9 mmHg, 1.82-fold higher in 40.0-49.9 mmHg and 2.11-fold higher in ≥50.0 mmHg groups (all p<0.001).

Conclusions:

New-onset pulmonary hypertension, as indicated by elevated eRVSP, is a common finding among older patients without left heart disease followed-up with echocardiography. This phenomenon is associated with an increased morality risk even among those with mildly elevated eRVSP.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: ERJ Open Res Year: 2023 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: ERJ Open Res Year: 2023 Document type: Article Affiliation country: Australia